BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 17570682)

  • 1. Functional evaluation of cerebral cortex in dementia with Lewy bodies.
    Di Lazzaro V; Pilato F; Dileone M; Saturno E; Profice P; Marra C; Daniele A; Ranieri F; Quaranta D; Gainotti G; Tonali PA
    Neuroimage; 2007 Aug; 37(2):422-9. PubMed ID: 17570682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo functional evaluation of central cholinergic circuits in vascular dementia.
    Di Lazzaro V; Pilato F; Dileone M; Profice P; Marra C; Ranieri F; Quaranta D; Gainotti G; Tonali PA
    Clin Neurophysiol; 2008 Nov; 119(11):2494-500. PubMed ID: 18829384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of transcranial magnetic stimulation in the in vivo functional evaluation of central cholinergic circuits in dementia.
    Nardone R; Golaszewski S; Ladurner G; Tezzon F; Trinka E
    Dement Geriatr Cogn Disord; 2011; 32(1):18-25. PubMed ID: 21822020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central cholinergic dysfunction measured "in vivo" correlates with different behavioral disorders in Alzheimer's disease and dementia with Lewy body.
    Marra C; Quaranta D; Profice P; Pilato F; Capone F; Iodice F; Di Lazzaro V; Gainotti G
    Brain Stimul; 2012 Oct; 5(4):533-8. PubMed ID: 22019082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies.
    Beyer MK; Larsen JP; Aarsland D
    Neurology; 2007 Aug; 69(8):747-54. PubMed ID: 17709706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced short latency afferent inhibition in patients with Down syndrome and Alzheimer-type dementia.
    Nardone R; Marth R; Ausserer H; Bratti A; Tezzon F
    Clin Neurophysiol; 2006 Oct; 117(10):2204-10. PubMed ID: 16931146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Motor cortex inhibitory circuits in dementia with Lewy bodies and in Alzheimer's disease.
    Nardone R; Bratti A; Tezzon F
    J Neural Transm (Vienna); 2006 Nov; 113(11):1679-84. PubMed ID: 17024328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Motor cortex cholinergic dysfunction in CADASIL: a transcranial magnetic demonstration.
    Manganelli F; Ragno M; Cacchiò G; Iodice V; Trojano L; Silvaggio F; Scarcella M; Grazioli M; Santoro L; Perretti A
    Clin Neurophysiol; 2008 Feb; 119(2):351-5. PubMed ID: 18065265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative electroencephalogram analysis in dementia with Lewy bodies and Alzheimer's disease.
    Kai T; Asai Y; Sakuma K; Koeda T; Nakashima K
    J Neurol Sci; 2005 Oct; 237(1-2):89-95. PubMed ID: 16019033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Motor cortex hyperexcitability to transcranial magnetic stimulation in Alzheimer's disease.
    Di Lazzaro V; Oliviero A; Pilato F; Saturno E; Dileone M; Marra C; Daniele A; Ghirlanda S; Gainotti G; Tonali PA
    J Neurol Neurosurg Psychiatry; 2004 Apr; 75(4):555-9. PubMed ID: 15026495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo cholinergic circuit evaluation in frontotemporal and Alzheimer dementias.
    Di Lazzaro V; Pilato F; Dileone M; Saturno E; Oliviero A; Marra C; Daniele A; Ranieri F; Gainotti G; Tonali PA
    Neurology; 2006 Apr; 66(7):1111-3. PubMed ID: 16606932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed blink reflex in dementia with Lewy bodies is sensitive to cholinergic modulation.
    Anzellotti F; Bonanni L; Iorio E; Di Baldassarre F; D'Andreagiovanni A; Monaco D; Thomas A; Onofrj M
    Clin Neuropharmacol; 2008; 31(4):231-7. PubMed ID: 18670247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The contribution of TMS to frontotemporal dementia variants.
    Alberici A; Bonato C; Calabria M; Agosti C; Zanetti O; Miniussi C; Padovani A; Rossini PM; Borroni B
    Acta Neurol Scand; 2008 Oct; 118(4):275-80. PubMed ID: 18397363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short latency afferent inhibition is not impaired in mild cognitive impairment.
    Sakuma K; Murakami T; Nakashima K
    Clin Neurophysiol; 2007 Jul; 118(7):1460-3. PubMed ID: 17462943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short latency afferent inhibition in Parkinson's disease patients with dementia.
    Celebi O; Temuçin CM; Elibol B; Saka E
    Mov Disord; 2012 Jul; 27(8):1052-5. PubMed ID: 22605543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Boston naming performance distinguishes between Lewy body and Alzheimer's dementias.
    Williams VG; Bruce JM; Westervelt HJ; Davis JD; Grace J; Malloy PF; Tremont G
    Arch Clin Neuropsychol; 2007 Nov; 22(8):925-31. PubMed ID: 17681741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative gait analysis in patients with dementia with Lewy bodies and Alzheimer's disease.
    Merory JR; Wittwer JE; Rowe CC; Webster KE
    Gait Posture; 2007 Sep; 26(3):414-9. PubMed ID: 17161601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Navigated TMS combined with EEG in mild cognitive impairment and Alzheimer's disease: a pilot study.
    Julkunen P; Jauhiainen AM; Westerén-Punnonen S; Pirinen E; Soininen H; Könönen M; Pääkkönen A; Määttä S; Karhu J
    J Neurosci Methods; 2008 Jul; 172(2):270-6. PubMed ID: 18533272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Motor cortex excitability in Alzheimer's disease and in subcortical ischemic vascular dementia.
    Alagona G; Ferri R; Pennisi G; Carnemolla A; Maci T; Domina E; Maertens de Noordhout A; Bella R
    Neurosci Lett; 2004 May; 362(2):95-8. PubMed ID: 15193762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurophysiological Correlates of Motor and Cognitive Dysfunction in Prodromal and Overt Dementia with Lewy Bodies.
    Benussi A; Pilotto A; Cantoni V; Ferrari E; Borroni B; Padovani A
    J Alzheimers Dis; 2022; 86(2):579-588. PubMed ID: 35094996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.